The means by which MI-319 (and p53) inhibit MDSC trafficking from the bone marrow to tumor tissue is not known but may involve the suppression of chemokine (e.g. SDF-1) production by tumor cells and stromal elements that were rendered hypoxic by the disruption of the tumor vasculature. Here, TP53 is linked to neoplasm.